IL103205A0 - Compounds for treating leukotriene-related diseases - Google Patents

Compounds for treating leukotriene-related diseases

Info

Publication number
IL103205A0
IL103205A0 IL103205A IL10320592A IL103205A0 IL 103205 A0 IL103205 A0 IL 103205A0 IL 103205 A IL103205 A IL 103205A IL 10320592 A IL10320592 A IL 10320592A IL 103205 A0 IL103205 A0 IL 103205A0
Authority
IL
Israel
Prior art keywords
compounds
related diseases
treating leukotriene
leukotriene
treating
Prior art date
Application number
IL103205A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL103205A0 publication Critical patent/IL103205A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Discharge Lamps And Accessories Thereof (AREA)
  • Cathode-Ray Tubes And Fluorescent Screens For Display (AREA)
IL103205A 1991-09-19 1992-09-17 Compounds for treating leukotriene-related diseases IL103205A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76271091A 1991-09-19 1991-09-19
US79093191A 1991-11-12 1991-11-12
US80959391A 1991-12-18 1991-12-18
US93286992A 1992-08-20 1992-08-20
CN93103596A CN1092409A (zh) 1991-09-19 1993-03-19 用于治疗白三烯有关的疾病的化合物

Publications (1)

Publication Number Publication Date
IL103205A0 true IL103205A0 (en) 1993-02-21

Family

ID=36809157

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103205A IL103205A0 (en) 1991-09-19 1992-09-17 Compounds for treating leukotriene-related diseases

Country Status (12)

Country Link
EP (1) EP0604529A1 (fr)
JP (1) JPH06510786A (fr)
CN (1) CN1092409A (fr)
AP (1) AP333A (fr)
AU (1) AU2573592A (fr)
CA (1) CA2119467A1 (fr)
IL (1) IL103205A0 (fr)
MA (1) MA22649A1 (fr)
MX (1) MX9205358A (fr)
NZ (1) NZ244371A (fr)
PT (1) PT100881A (fr)
WO (1) WO1993006085A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ254473A (en) * 1992-06-30 1996-11-26 Smithkline Beecham Corp Preparation of phenylthiomethylpyridinylalkenoates
GB9313145D0 (en) * 1993-06-25 1993-08-11 Smithkline Beecham Plc Process
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
DK0812194T3 (da) * 1995-03-02 2000-12-18 Smithkline Beecham Corp Fremgangsmåde til behandling af atopisk dermatitis og kontaktdermatitis
GB9508137D0 (en) * 1995-04-21 1995-06-07 Smithkline Beecham Plc Formulation
GB9602166D0 (en) 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
US6313127B1 (en) 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
CN1228087A (zh) * 1996-08-14 1999-09-08 曾尼卡有限公司 取代的嘧啶衍生物和它们的药物用途
AU4557397A (en) * 1996-09-26 1998-04-17 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
JP2001511798A (ja) 1997-02-13 2001-08-14 ゼネカ・リミテッド オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物
DE69815509T2 (de) 1997-02-13 2004-05-13 Astrazeneca Ab Heterozyklische verbindungen die als oxido-squalen-zyklase-inhibitoren anwendung finden
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056619A (en) * 1975-09-08 1977-11-01 Warner-Lambert Company 1-Substituted-2-(2-pyridinyl)ethanone N-oxides
US5004743A (en) * 1987-11-25 1991-04-02 Merck Frosst Canada, Inc. Pyridyl styrene dialkanoic acids as anti-leukotriene agents
JPH07116150B2 (ja) * 1990-06-07 1995-12-13 スミスクライン・ビーチャム・コーポレイション 安息香酸誘導体

Also Published As

Publication number Publication date
AU2573592A (en) 1993-04-27
MX9205358A (es) 1993-07-01
EP0604529A1 (fr) 1994-07-06
MA22649A1 (fr) 1993-04-01
AP333A (en) 1994-04-25
AP9200428A0 (en) 1992-10-31
CA2119467A1 (fr) 1993-04-01
JPH06510786A (ja) 1994-12-01
PT100881A (pt) 1993-10-29
CN1092409A (zh) 1994-09-21
WO1993006085A1 (fr) 1993-04-01
NZ244371A (en) 1995-11-27

Similar Documents

Publication Publication Date Title
EP0714302A4 (fr) Composes therapeutiques
GB9127150D0 (en) Novel treatment
AP9200453A0 (en) Medicaments for treating inflammatory conditions or for analgiesia
IL103205A0 (en) Compounds for treating leukotriene-related diseases
GB9310199D0 (en) Therapeutic compounds
IL98387A0 (en) Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
AP9400637A0 (en) Therapeutic c compounds
GB9117819D0 (en) Therapeutic compounds
ZA942911B (en) Therapeutic compounds
GB9214239D0 (en) Compounds useful for treating tumours
ZA927160B (en) Compounds for treating leukotriene-related diseases.
GB9124541D0 (en) Therapeutic compounds
GB9102340D0 (en) Therapeutic compounds
GB9102341D0 (en) Therapeutic compounds
GB9102376D0 (en) Therapeutic compounds
GB9020266D0 (en) Therapeutic compounds
GB9000691D0 (en) Therapeutic compounds
GB9226526D0 (en) Therapeutic compounds
GB9222934D0 (en) Therapeutic compounds
HK1012369A (en) Pyridine compounds for treating leukotriene-related diseases
GB9114335D0 (en) Compounds useful for treating tumours
GB9127354D0 (en) Agents for therapy
HU902560D0 (en) Arrangement for sowing-seed treatment
BG96320U (en) Compound for skin treatment
GB8815250D0 (en) Compounds for preventing/treating inflammatory & degenerative diseases